Abarelix dosing & administration
GnRH Antagonist for Advanced Prostate Cancer Treatment
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Dosing
How much do I take?
Intramuscular: An injection into a muscle, usually the thigh, shoulder, or buttock.
Bioavailability High — well absorbed into the bloodstream from the muscle.
100 mg
Frequency
Day 1, 15, 29, then every 4 weeks
Duration
Up to 12 months (effectiveness beyond 12 months not established)
This is the FDA-approved dose for advanced prostate cancer. A 100 mg shot is given into the buttock muscle on day 1, 15, and 29, then once every 4 weeks. The drug was sold as Plenaxis. [4]
Timing
Best time to take
Administer Abarelix at the same time each day (or on the same day each week for weekly injections). Many users prefer morning or evening administration. Pick a time you'll remember consistently.
With food?
Abarelix injections can be given regardless of meal timing. However, if GI effects occur, administering on an empty stomach or with a light meal may help reduce discomfort.
If stacking
Abarelix should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
Adjusting your dose
Increase if
- You've tolerated the current dose for the recommended period without significant side effects
- Therapeutic goals haven't been met at the current dose level
- Your healthcare provider recommends dose escalation based on your response
- Lab work or clinical assessments support a higher dose
Decrease if
- Side effects are bothersome or impacting daily life despite management strategies
- You experience any signs of an adverse reaction
- Lab results indicate the need for dose reduction
- Your healthcare provider recommends a lower dose based on your response
Signs of right dose
- Therapeutic goals being met with minimal side effects
- Stable and consistent response to treatment
- Lab values or clinical markers trending in the right direction
- Good tolerance with manageable or absent side effects
Administration
How do I use it?
Reconstitution
What you need
Injection
Route
Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training
Best sites
Storage
Before reconstitution
Store Abarelix in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
After reconstitution
Once reconstituted, Abarelix should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Signs of degradation — discard the vial
Sample daily schedule
As prescribed (once daily)
As prescribed by your healthcare provider injection
Site: Intramuscular injection (depot formulation)—rotate sites if applicable
Maintain a consistent schedule for optimal results with Abarelix. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.
Safety
Is it safe?
Side effects
Commonly reported: Mild discomfort at treatment site, Hot flashes and sweating, Decreased libido and sexual dysfunction, Increased liver enzymes, Injection site reactions (pain, redness, swelling), Abdominal pain and gastrointestinal symptoms, Headache and dizziness, Weight changes, Gynecomastia (breast tissue enlargement), Bone density loss with long-term use
Stop and seek help if
- Severe or worsening side effects that don't improve with dose adjustment or supportive care
- Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- Your healthcare provider recommends discontinuation based on your clinical response
- Development of any new medical condition that may be contraindicated with Abarelix
- Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- Abnormal lab results or clinical markers that suggest adverse effects
Abarelix should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Flagged pairings
- Other GnRH agonists simultaneously — Use with caution—discuss with your healthcare provider.
- Certain antiandrogens without medical supervision — Use with caution—discuss with your healthcare provider.
Published research
What the studies show
Patel S, Saxena B, Mehta P · 2024
GnRH antagonists like abarelix provide rapid testosterone suppression without the initial hormone surge seen with agonists. These peptides offer faster onset of action and lower cardiovascular risk, making them revolutionary therapy for advanced prostate cancer and other hormone-dependent diseases.
Moul JW · 2014
Degarelix, as an LHRH antagonist, achieved very rapid testosterone suppression with no testosterone surge unlike agonists. Clinical studies showed patients experienced sustained suppression below castration levels with better disease control than traditional LHRH agonists.
Van Poppel H, Klotz L · 2012
GnRH antagonists achieved faster castration, suppressed prostate-specific antigen more effectively, and avoided testosterone surge altogether. These benefits suggested antagonists could replace agonists as first-line therapy, potentially delaying the onset of castration-resistant disease.
U.S. Food and Drug Administration · 2003
Recommended dose is 100 mg administered intramuscularly to the buttock on Day 1, 15, 29 (week 4) and every 4 weeks thereafter; effectiveness beyond 12 months not established.
Head to head
Abarelix compared
Want the full picture?
The complete Abarelix research profile: mechanism of action, clinical studies, effectiveness timeline, and FAQ.